CLORAZEPATE DIPOTASSIUM - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for clorazepate dipotassium and what is the scope of patent protection?

Clorazepate dipotassium is the generic ingredient in four branded drugs marketed by Able, Am Therap, Dash Pharms, Dava Pharms Inc, Gd Searle Llc, Purepac Pharm, Quantum Pharmics, Rising, Usl Pharma, Warner Chilcott, Watson Labs, Ajenat Pharms, Aurobindo Pharma, Aurolife Pharma Llc, Corepharma, Lederle, Novitium Pharma, Sun Pharm Inds Ltd, Taro, and Alra, and is included in sixty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for clorazepate dipotassium. Seven suppliers are listed for this compound.

Summary for CLORAZEPATE DIPOTASSIUM

US Patents:	0
Tradenames:	4
Applicants:	20
NDAs:	62
Drug Master File Entries:	7
Finished Product Suppliers / Packagers:	7
Raw Ingredient (Bulk) Api Vendors:	18
Clinical Trials:	2
Patent Applications:	661
Drug Prices:	Drug price trends for CLORAZEPATE DIPOTASSIUM
What excipients (inactive ingredients) are in CLORAZEPATE DIPOTASSIUM?	CLORAZEPATE DIPOTASSIUM excipients list
DailyMed Link:	CLORAZEPATE DIPOTASSIUM at DailyMed

See drug prices for CLORAZEPATE DIPOTASSIUM

Recent Clinical Trials for CLORAZEPATE DIPOTASSIUM

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Assistance Publique - Hôpitaux de Paris	Phase 3
Ranbaxy Laboratories Limited	N/A

See all CLORAZEPATE DIPOTASSIUM clinical trials

Pharmacology for CLORAZEPATE DIPOTASSIUM

Drug Class	Benzodiazepine

Medical Subject Heading (MeSH) Categories for CLORAZEPATE DIPOTASSIUM

Anti-Anxiety Agents
Anticonvulsants
GABA Modulators

US Patents and Regulatory Information for CLORAZEPATE DIPOTASSIUM

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Able	CLORAZEPATE DIPOTASSIUM	clorazepate dipotassium	TABLET;ORAL	071780-001	Jun 26, 1987		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Warner Chilcott	CLORAZEPATE DIPOTASSIUM	clorazepate dipotassium	TABLET;ORAL	071828-001	Mar 3, 1988		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Purepac Pharm	CLORAZEPATE DIPOTASSIUM	clorazepate dipotassium	TABLET;ORAL	072330-001	Aug 8, 1988		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ajenat Pharms	TRANXENE	clorazepate dipotassium	TABLET;ORAL	017105-008	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for CLORAZEPATE DIPOTASSIUM

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Ajenat Pharms	TRANXENE	clorazepate dipotassium	TABLET;ORAL	017105-006	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Ajenat Pharms	TRANXENE SD	clorazepate dipotassium	TABLET;ORAL	017105-004	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Ajenat Pharms	TRANXENE	clorazepate dipotassium	CAPSULE;ORAL	017105-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Ajenat Pharms	TRANXENE	clorazepate dipotassium	TABLET;ORAL	017105-007	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.